{"SPADE_UN_28726": {"Sequence Information": {"Peptide Name": "", "Sequence": "TTWEAWDRAIAEYAARIEALIRALQELQEKNEAALREL", "Sequence Length": 38, "Biological Activity": ["Antiviral"], "Binding Target": "1. gp41\n2. Virus replication", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "Q70626", "uniprotUrl": "http://www.uniprot.org/uniprot/Q70626", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}], "Literature": [{"Title": "Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.", "Pubmed ID": "17640899", "Reference": "Proc Natl Acad Sci U S A. 2007;104:12772-12777", "Author": "Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/17640899"}], "Mass": 4442.94, "PI": 4.64, "Net Charge": -3, "Hydrophobicity": -0.43, "Frequent Amino Acids": "AEL", "Absent Amino Acids": "CFGHMOPSUV", "Basic Residues": 5, "Acidic Residues": 8, "Hydrophobic Residues": 17, "Polar Residues": 21, "Positive Residues": 5, "Negative Residues": 8, "SPADE ID": "SPADE_UN_28726", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_09781", "Similarity": 1.0, "Sequence": "TTWEAWDRAIAE"}, {"SPADE_ID": "SPADE_UN_09785", "Similarity": 1.0, "Sequence": "TTWEAWDRAIA"}, {"SPADE_ID": "SPADE_UN_09787", "Similarity": 1.0, "Sequence": "TTWEAWDRAI"}], "Hemolytic Activity": "", "Target Organism": "HIV-1 IIIB(IC50 REP=0.03µg/ml),HIV-1 098(IC50 REP=0.054µg/ml),HIV-1 098-T20(IC50 REP=0.084µg/ml),HIV-1 098-T1249(IC50 REP=0.147µg/ml),HIV-1 098-T651(IC50 REP=0.242µg/ml)"}}}